Introduction Despite a large preclinical literature demonstrating neuroprotective effects of
estrogen, use of menopausal hormone therapy (HT) for Alzheimer's disease (AD) risk …

Hormone therapy (HT) has been used in postmenopausal women for decades in clinical
practice. With further analysis and newer studies, the benefits and risks of HT have been …

The greater prevalence and incidence of Parkinson's disease (PD) in men suggest a
beneficial effect of sex hormones. Neuroactive steroids have neuroprotective activities thus …

Parkinson's disease has been found to significantly affect health-related quality of life. The
gender differences of the health-related quality of life of subjects with Parkinson's disease …

Emerging evidence indicates that the enhancement of microglial autophagy inhibits the
NLRP3 inflammasome mediated neuroinflammation in Alzheimer's disease (AD) …

Dementia is a pandemic chronic non-communicable disease. 10 in 100 women above age
65 will be diagnosed with dementia, primarily Alzheimer's disease (AD). Apart from age and …

A better understanding of interindividual differences and the development of targeted
therapies is one of the major challenges of modern medicine. The sex of a person plays a …

Age-related diseases account for almost half of all diseases among adults worldwide, and
their incidence is substantially affected by the exposome, which is the sum of all exogenous …

It is well known that vascular factors and specific social determinants of health contribute to
dementia risk and that the prevalence of these risk factors differs according to race and sex …

Sex is a biological variable that contributes to individual variability in brain structure and
behavior. Neuroimaging studies of population‐based samples have identified normative …